Table 2 WHO three essential antipsychotics and other drugs on the 'Essential' list (by drug class) to which they have been compared within randomized trials
From: Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
RCTs | Total number of people | Cochrane review | Reference | Up to date? | |
|---|---|---|---|---|---|
Chlorpromazine | |||||
   vs anticonvulsant agents | 2 | 118 | ✗ | ||
   vs antidepressants | 12 | 732 | ✓ | ✗ | |
   vs antihypertensive agents | 8 | 286 | ✗ | ||
   vs antiparkinsonian agents | 3 | 80 | ✗ | ||
   vs antituberculosis agents | 1 | 25 | ✗ | ||
   vs barbiturates | 3 | 750 | ✗ | ||
   vs benzodiazepines | 9 | 457 | ✓ | ✗ | |
   vs mood stabilizers | 2 | 49 | ✓ | ✗ | |
   vs opioid agonist | 1 | 340 | ✗ | ||
   vs opioid antagonist | 1 | 60 | ✗ | ||
Fluphenazine decanoate | |||||
   vs antihypertensive agents | 1 | 17 | ✗ | ||
   vs antituberculosis agents | 1 | 55 | ✗ | ||
Haloperidol | |||||
   vs antiarrhythmic agents | 2 | 30 | ✗ | ||
   vs antidepressants | 10 | 774 | ✓ | ✗ | |
   vs antidopaminergic agents | 4 | 146 | ✗ | ||
   vs antigout agents | 1 | 46 | ✗ | ||
   vs antihypertensive agents | 3 | 122 | ✗ | ||
   vs antineoplastic agents | 3 | 101 | ✗ | ||
   vs antiparkinsonian agents | 8 | 265 | ✗ | ||
   vs antiprogesterone agents | 1 | 80 | ✓ | [29] | ✗ |
   vs benzodiazepines | 35 | 4012 | ✓ | ✗ | |
   vs ethanol | 1 | 35 | ✗ | ||
   vs glucose | 1 | unclear | ✗ | ||
   vs mood stabilizers | 23 | 1648 | ✓ | ✗ | |
   vs stimulant agents | 1 | 20 | ✗ | ||